NexGel Inc. (NXGL) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NexGel Inc. (NXGL:NASDAQ), powered by AI.

Current Price
$0.58
P/E Ratio
-1.2
Market Cap
4M
Sector
Healthcare
What is the NexGel Inc. stock price forecast?

NexGel Inc. is currently trading at $0.58. View real-time AI analysis on Alpha Lenz.

What is NexGel Inc. insider trading activity?

View the latest insider trading data for NexGel Inc. on Alpha Lenz.

What is NexGel Inc.'s P/E ratio?

NexGel Inc.'s P/E ratio is -1.2.

NexGel Inc.

NASDAQ · NXGL
$0.58
Ask about NexGel Inc.'s future dividend policy...
Alpha Chat Insight

NexGel Inc. trades at a P/E of -1.2 (undervalued) with modest ROE of -62.8%. 3Y revenue CAGR of 77.6% highlights clear growth momentum.

Ask for details

Company Overview

NexGel Inc. focuses on the development and production of high-performance hydrogels for healthcare and consumer applications. These hydrogels are used in a variety of niche applications due to their versatile and flexible nature. NexGel's primary function is to serve within the wound care, medical diagnostic, and personal care sectors by providing advanced hydrogel solutions that optimize functionality, comfort, and efficacy. The company's hydrogels are noted for their unique composition, which can be customized to adhere, absorb, or deliver active ingredients effectively. The healthcare industry benefits significantly from NexGel's technology, especially in areas requiring contact dressings and transdermal treatments. NexGel Inc. plays a critical role in enabling medical advancements by providing products that improve patient outcomes through better moisture management and skin-friendly properties. By addressing specific needs in the market with its innovative product line, NexGel Inc. continues to strengthen its position as a key contributor to the advancement of healthcare materials. This focus allows the company to maintain relevancy and capture growth in evolving medical and personal care markets.

CEOMr. Adam R. Levy
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees19

Company Statistics

FY 2024

Profile

$3.78MMarket Cap
$8.69MRevenue
0.00Shares Out
19Employees

Margins

31.63%Gross
-34.32%EBITDA
-40.91%Operating
-39.86%Pre-Tax
-39.86%Net

Valuation

-1.15P/E
0.66P/B
0.44EV/Sales
-1.72EV/EBITDA
-0.88P/FCF

Growth (CAGR)

77.60%Rev 3Yr
64.69%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-33.08%ROA
-62.78%ROE
-32.30%ROIC

Financial Health

$1.81MCash & Cash Equivalents
$3.10MNet Debt
80.64%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

NexGel Inc. (ticker: NXGL) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 19 employees. Market cap is $4M.

The current price is $0.581 with a P/E ratio of -1.15x and P/B of 0.66x.

ROE is -62.78% and operating margin is -40.91%. Annual revenue is $9M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
NexGel Inc. (Healthcare) Stock Forecast & Analysis $0.58 | Alpha Lenz